Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With NIDDM: a Placebo-controlled Dose-response Study With Insulin Aspart (Novorapid®)

NCT00771693 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT00771693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00771693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With NIDDM: a Placebo-controlled Dose-response Study With Insulin Aspart (Novorapid®)
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2007
Completion date
July 31, 2011
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postprandial hyperglycemia, type 2 diabetes mellitus